Sintx Technologies (SINT) Current Deferred Revenue (2013 - 2018)
Sintx Technologies (SINT) posted quarterly Current Deferred Revenue of $169000.0 for Q4 2018, up 196.49% quarter-over-quarter from $57000.0 in Q4 2014.
Sintx Technologies (SINT) Current Deferred Revenue (2013 - 2018) Analysis & Trends
Sintx Technologies' Current Deferred Revenue history runs 3 years deep, the most recent figure standing at $169000.0 for Q4 2018.
- In Q4 2018, Current Deferred Revenue changed N/A year-over-year to $169000.0; the TTM figure through Dec 2018 stood at $169000.0 (changed N/A YoY), while the FY2018 annual figure was $169000.0, changed N/A from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $169000.0, up from $57000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $169000.0 in Q4 2018, with the low at $37000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.88 Bn | 197.28 Bn | 7.27 Bn |
| 2 | Stryker | 126.34 Bn | 122.87 Bn | 4.50 Bn |
| 3 | Medtronic | 119.78 Bn | 110.56 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.35 Bn | 73.81 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.73 Bn | 47.47 Bn | 1.35 Bn |
| 6 | Dexcom | 35.36 Bn | 33.41 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.23 Bn | 22.91 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 7.47 Mn | 7.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 169,000.00 |
| Dec 31, 2014 | 57,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 43,000.00 |
| Mar 31, 2014 | 37,000.00 |
| Dec 31, 2013 | 32,000.00 |